Year 2022 / Volume 114 / Number 10
Original
Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma

580-585

DOI: 10.17235/reed.2022.8592/2022

Weike Chu, Ping Li, Xue Wu, Peng Zhang, Hui Zhou, Bin Niu,

Abstract
This study aimed to determine the risk factors of recurrence beyond Milan criteria in patients with transplantable early hepatocellular carcinoma (HCC) after the first Radiofrequency ablation (RFA). 95 patients with newly diagnosed transplantable small HCC with single ≤3 cm lesions were analyzed retrospectively. During the 39-month median follow-up period, 12 (21.8%) patients with HCC < 2 cm and 22 (56.4%) patients with HCC ≥ 2 cm relapsed beyond Milan criteria (p = 0.001). The 1- and 3-year recurrence rates beyond Milan criteria were 6.3% and 14.7% in the HCC <2 cm group, compared with 24.1% and 55.6% in HCC ≥2 cm group (p < 0.0001). HCC ≥2 cm, red blood cell distribution width-to-lymphocyte ratio (RLR) ≥ 18.3, alpha-fetoprotein (AFP) >15 ng/ml and early recurrence after RFA were independent predictors of recurrence exceeding Milan criteria. Close follow-up and early liver transplantation should be initiated to obtain the best survival benefit for patients with transplantable early single small HCC with a tumor diameter ≥2 cm and higher RLR and AFP levels before the first RFA and early recurrence after RFA (recurrence within 2 years).
Share Button
New comment
Comments
No comments for this article
References
Yang, J.D., Hainaut, P., Gores, G.J., et al. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 16(10), 589-604. http://doi.org/10.1038/s41575-019-0186-y (2019)
Forner, A., Reig, M. &Bruix, J. Hepatocellular carcinoma. The Lancet. 391(10127), 1301-1314. http://doi.org/10.1016/s0140-6736(18)30010-2 (2018)
Cucchetti, A., Piscaglia, F., Cescon, M., et al. Cost-effectiveness of hepatic resection versus percutaneous radiofrequency ablation for early hepatocellular carcinoma. J Hepatol. 59(2), 300-7. http://doi.org/10.1016/j.jhep.2013.04.009 (2013)
European Association for the Study of the Liver. Electronic address, e.e.e. &European Association for the Study of the, L. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol. 69(1), 182-236. http://doi.org/10.1016/j.jhep.2018.03.019 (2018)
Heimbach, J.K., Kulik, L.M., Finn, R.S., et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 67(1), 358-380. http://doi.org/10.1002/hep.29086 (2018)
Mazzaferro, V., Regalia, E., Doci, R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. The New England journal of medicine. 334(11), 693-699. (1996)
Clavien, P.-A., Lesurtel, M., Bossuyt, P.M.M., et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. The Lancet. Oncology. 13(1), e11-e22. http://doi.org/10.1016/S1470-2045(11)70175-9 (2012)
Marrero, J.A., Kulik, L.M., Sirlin, C.B., et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 68(2), 723-750. http://doi.org/10.1002/hep.29913 (2018)
Mazzaferro, V. Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. Hepatology (Baltimore, Md.). 63(5), 1707-1717. http://doi.org/10.1002/hep.28420 (2016)
Lim, K.C., Wang, V.W., Siddiqui, F.J., et al. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology. 61(1), 227-37. http://doi.org/10.1002/hep.27135 (2015)
Sapisochin, G. &Bruix, J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 14(4), 203-217. http://doi.org/10.1038/nrgastro.2016.193 (2017)
Tsuchiya, K., Asahina, Y., Tamaki, N., et al. Risk factors for exceeding the Milan criteria after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma. Liver Transpl. 20(3), 291-7. http://doi.org/10.1002/lt.23798 (2014)
Doyle, A., Gorgen, A., Muaddi, H., et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3cm in potentially transplantable patients. J Hepatol. 70(5), 866-873. http://doi.org/10.1016/j.jhep.2018.12.027 (2019)
Bruix, J., Sherman, M. &American Association for the Study of Liver, D. Management of hepatocellular carcinoma: an update. Hepatology. 53(3), 1020-2. http://doi.org/10.1002/hep.24199 (2011)
O'Leary, J.G., Lepe, R. &Davis, G.L. Indications for liver transplantation. Gastroenterology. 134(6), 1764-1776. http://doi.org/10.1053/j.gastro.2008.02.028 (2008)
Pompili, M., Saviano, A., de Matthaeis, N., et al. Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey. Journal of hepatology. 59(1), 89-97. http://doi.org/10.1016/j.jhep.2013.03.009 (2013)
Cho, J.Y., Choi, M.S., Lee, G.S., et al. Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma. Clin Mol Hepatol. 22(4), 477-486. http://doi.org/10.3350/cmh.2016.0048 (2016)
Kim, Y.-s., Lim, H.K., Rhim, H., et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. Journal of hepatology. 58(1), 89-97. http://doi.org/10.1016/j.jhep.2012.09.020 (2013)
Lee, H.Y., Rhim, H., Lee, M.W., et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. European radiology. 23(1), 190-197. http://doi.org/10.1007/s00330-012-2561-8 (2013)
Lu, X.-Y., Xi, T., Lau, W.-Y., et al. Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior. Journal of cancer research and clinical oncology. 137(4), 567-575. http://doi.org/10.1007/s00432-010-0909-5 (2011)
Mitsuhashi, N., Kobayashi, S., Doki, T., et al. Clinical significance of alpha-fetoprotein: involvement in proliferation, angiogenesis, and apoptosis of hepatocellular carcinoma. Journal of gastroenterology and hepatology. 23(7 Pt 2), e189-e197. http://doi.org/10.1111/j.1440-1746.2008.05340.x (2008)
Zheng, Y., Zhu, M. &Li, M. Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma. J Cancer Res Clin Oncol. 146(10), 2439-2446. http://doi.org/10.1007/s00432-020-03331-6 (2020)
Tateishi, R., Shiina, S., Yoshida, H., et al. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers. Hepatology (Baltimore, Md.). 44(6), 1518-1527. (2006)
Ueno, M., Hayami, S., Shigekawa, Y., et al. Prognostic impact of surgery and radiofrequency ablation on single nodular HCC ⩽5 cm: Cohort study based on serum HCC markers. Journal of hepatology. 63(6), 1352-1359. http://doi.org/10.1016/j.jhep.2015.07.013 (2015)
Grivennikov, S.I., Greten, F.R. &Karin, M. Immunity, inflammation, and cancer. Cell. 140(6), 883-899. http://doi.org/10.1016/j.cell.2010.01.025 (2010)
Cruz, J.C., Watchmaker, J.M., Albin, M.M., et al. Neutrophil/Lymphocyte Ratio Predicts Increased Risk of Immediate Progressive Disease following Chemoembolization of Hepatocellular Carcinoma. Journal of vascular and interventional radiology : JVIR. 30(12), 1887-1892. http://doi.org/10.1016/j.jvir.2019.08.001 (2019)
Mano, Y., Shirabe, K., Yamashita, Y.-I., et al. Preoperative neutrophil-to-lymphocyte ratio is a predictor of survival after hepatectomy for hepatocellular carcinoma: a retrospective analysis. Annals of surgery. 258(2), 301-305. http://doi.org/10.1097/SLA.0b013e318297ad6b (2013)
Huang, J., Zhao, Y., Liao, L., et al. Evaluation of Red Cell Distribution Width to Lymphocyte Ratio as Potential Biomarker for Detection of Colorectal Cancer. Biomed Res Int. 2019, 9852782. http://doi.org/10.1155/2019/9852782 (2019)
Wang, S., Deng, Y., Yu, X., et al. Prognostic significance of preoperative systemic inflammatory biomarkers in patients with hepatocellular carcinoma after microwave ablation and establishment of a nomogram. Scientific reports. 11(1), 13814. http://doi.org/10.1038/s41598-021-93289-3 (2021)
Wang, C., Zhao, K., Hu, S., et al. A predictive model for treatment response in patients with locally advanced esophageal squamous cell carcinoma after concurrent chemoradiotherapy: based on SUVmean and NLR. BMC cancer. 20(1), 544. http://doi.org/10.1186/s12885-020-07040-8 (2020)
Rashid, F., Waraich, N., Bhatti, I., et al. A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World journal of surgical oncology. 8, 1. http://doi.org/10.1186/1477-7819-8-1 (2010)
Chen, Y., Yang, Y., Zhang, X.-Y., et al. Nomogram Based on Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio to Predict Recurrence in Patients with Hepatocellular Carcinoma after Radiofrequency Ablation. Cardiovascular and interventional radiology. http://doi.org/10.1007/s00270-021-02872-8 (2021)
Goyal, H. &Hu, Z.D. Prognostic value of red blood cell distribution width in hepatocellular carcinoma. Ann Transl Med. 5(13), 271. http://doi.org/10.21037/atm.2017.06.30 (2017)
Wu, J., Zhang, X., Liu, H., et al. RDW, NLR and RLR in predicting liver failure and prognosis in patients with hepatitis E virus infection. Clin Biochem. 63, 24-31. http://doi.org/10.1016/j.clinbiochem.2018.11.012 (2019)
Zhang, X., Wang, D., Chen, Z., et al. Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis. Medicine. 99(23), e20638. http://doi.org/10.1097/MD.0000000000020600 (2020)
Related articles

Editorial

Hemophilia and hepatology, back to the future

DOI: 10.17235/reed.2024.10105/2023

Letter

Recurrence of gastric schwannoma

DOI: 10.17235/reed.2023.9480/2023

Digestive Diseases Image

Giant cystic hepatocarcinoma in the absence of cirrhosis

DOI: 10.17235/reed.2021.8313/2021

Letter

Biopsy for hepatocellular carcinoma: only occasionally

DOI: 10.17235/reed.2020.6935/2020

Letter

Hepatocarcinoma diagnosis. Reflection is required

DOI: 10.17235/reed.2020.6845/2019

Letter

Rhabdomyolysis in a patient under treatment with sorafenib

DOI: 10.17235/reed.2020.6440/2019

Case Report

Ectopic hepatocellular carcinoma arising from the peritoneum

DOI: 10.17235/reed.2019.6408/2019

Digestive Diseases Image

Debut of an unusual liver cirrhosis

Review

New challenges in clinical research on hepatocellular carcinoma

DOI: 10.17235/reed.2015.4012/2015

Citation tools
Chu W, Li P, Wu X, Zhang P, Zhou H, Niu B, et all. Risk factors for recurrence beyond Milan criteria after radiofrequency ablation in transplantable small hepatocellular carcinoma. 8592/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1826 visits.
This article has been downloaded 79 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 11/01/2022

Accepted: 18/01/2022

Online First: 19/01/2022

Published: 07/10/2022

Article revision time: 6 days

Article Online First time: 8 days

Article editing time: 269 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology